FDA Recalls Vitality Capsules Over Hidden ED Drugs

March 4, 2025
2 mins read
Represntative image: Drug Capsules Photo Source: fda.gov
Represntative image: Drug Capsules Photo Source: fda.gov

One Source Nutrition has issued a voluntary nationwide recall of all Vitality male enhancement capsules after FDA tests found them to contain sildenafil and tadalafil – prescription drugs used to treat erectile dysfunction that weren’t disclosed on the product label.

The March 3 announcement expands on the company’s initial February 20 recall to include all packaging styles of the product. The capsules were distributed to retail outlets across the country by wholesale distributors.

Health Risks Prompt Urgent Action

The FDA warns that these undeclared ingredients pose serious health risks. Tadalafil can interact with nitrates found in some prescription medications (such as nitroglycerin), potentially causing a dangerous drop in blood pressure. This interaction is particularly risky for men with diabetes, high blood pressure, high cholesterol, or heart disease – precisely the demographic most likely to use both nitrates and male enhancement products.

“Products containing sildenafil and tadalafil cannot be marketed as dietary supplements,” the FDA notes in the recall notice. The agency classifies Vitality capsules as “an unapproved new drug for which safety and efficacy have not been established.”

Identifying Affected Products

Consumers should look for Vitality capsules packaged either:

  • As a single pill in an orange and gray package with blue writing, or
  • In bottles containing six pills

The products lack lot numbers or expiration dates, making the packaging the primary means of identification.


Similar Post


Company Response

One Source Nutrition is notifying distributors and customers via email and arranging for the return of all recalled products. According to the company’s statement, no adverse events related to the recall have been reported so far.

Consumers with questions can contact One Source Nutrition at 501-778-3311 or [email protected] on weekdays between 10 a.m. and 6 p.m. CST.

Consumer Action Steps

Anyone who purchased Vitality capsules should:

  1. Stop using the product immediately
  2. Return it to the place of purchase
  3. Contact their healthcare provider if they’ve experienced any adverse effects

Adverse reactions can be reported to the FDA’s MedWatch Adverse Event Reporting program.

Industry Context

This recall highlights the ongoing challenge of undeclared pharmaceutical ingredients in dietary supplements, particularly in the male enhancement category. The FDA regularly identifies such products through its testing program, as supplements marketed for sexual enhancement, weight loss, and bodybuilding are most likely to contain hidden drug ingredients.

FAQ :

What exactly is being recalled and why?

All lots of Vitality male enhancement dietary supplement capsules are being recalled because FDA testing found they contain undeclared sildenafil and tadalafil, which are prescription drugs used to treat erectile dysfunction. These ingredients cannot legally be included in dietary supplements and pose serious health risks when not used under medical supervision.

How can I identify if I have the recalled product?

The recalled Vitality capsules come either as a single pill in an orange and gray package with blue writing or in bottles containing six pills. The products don’t have lot numbers or expiration dates, so identification is primarily by packaging appearance.

What health risks are associated with this recall?

The main health risk is that the undeclared tadalafil can interact with nitrates found in some prescription drugs (like nitroglycerin), potentially causing a life-threatening drop in blood pressure. People with diabetes, high blood pressure, high cholesterol, or heart disease who often take nitrates are at highest risk, particularly adult males.

What should I do if I have the recalled product?

Stop using the product immediately, return it to the place of purchase, and contact your doctor if you’ve experienced any adverse effects. You can also report any adverse reactions to the FDA’s MedWatch Adverse Event Reporting program.

Has anyone been harmed by using this product?

According to One Source Nutrition’s statement in the FDA recall notice, no adverse events related to this recall have been reported as of March 3, 2025.

How can I contact the company about this recall?

Consumers with questions can contact One Source Nutrition Inc. at 501-778-3311 or email [email protected] Monday through Friday from 10am to 6pm CST.

Tejal Somvanshi

Meet Tejal Somvanshi, a soulful wanderer and a staunch wellness advocate, who elegantly navigates through the enchanting domains of Fashion and Beauty with a natural panache. Her journey, vividly painted with hues from a vibrant past in the media production world, empowers her to carve out stories that slice through the cacophony, where brands morph into characters and marketing gimmicks evolve into intriguing plot twists. To Tejal, travel is not merely an activity; it unfolds as a chapter brimming with adventures and serendipitous tales, while health is not just a regimen but a steadfast companion in her everyday epic. In the realms of fashion and beauty, she discovers her muse, weaving a narrative where each style narrates a story, and every beauty trend sparks a dialogue. Tejal seamlessly melds the spontaneous spirit of the media industry with the eloquent prose of a storyteller, crafting tales as vibrant and dynamic as the industry she thrives in.

Leave a Reply

Your email address will not be published.

Representative Image: A mosquito feeding on human skin. Photo Source: (animalia.bio/aedes-cinereus)
Previous Story

Second Japanese Encephalitis Case Confirmed in Northern Victoria

Representative Image. The holotype, or specimen upon which a new species description is based, for Orchistoma integrale. Photo Source: Ryoya Sugimoto (NOAA Fisheries)
Next Story

Japanese Student’s Discovery: New Jellyfish Species Challenges Marine Biology Norms

Latest from Health

Representative Image. Glenmark building, blue glass facade. Photo Source: Glenmark Pharma.

Glenmark Recalls 1.5M ADHD Drug Bottles Over Carcinogen Risk

Glenmark Pharmaceuticals has recalled approximately 1.5 million bottles of Atomoxetine Capsules from the US market after tests found potentially harmful impurities above FDA-approved limits. The medication, used to treat attention deficit hyperactivity
The man operating a medical or cosmetic laser device, performing a procedure requiring hygiene and safety precautions. Photo Source: Pexels (Pavel Danilyuk)

Bowel Cancer Rates Soar Among Young Australians

Bowel cancer rates in young Australians have more than doubled since 2000, with experts suggesting diet choices and environmental factors may be behind the alarming trend. The disease has become the deadliest
Father Daughter Forest Walk. Photo Source: negativespace

Daughters Add 74 Weeks to Fathers’ Lifespans

A recent study from Jagiellonian University reveals that fathers with daughters tend to live longer than those without – specifically adding 74 weeks to a father’s life for each daughter born. The

Don't Miss

Representative Image: Hospital Clínic Barcelona @franciscoavia, Photo Source: Hospital Clínic (CC BY-ND 2.0)

Texas Measles Outbreak: 146 Cases, First U.S. Death Since 2015

The recent measles outbreak in Texas has claimed